Performance-based risk-sharing agreements in renal care: current experience and future prospects

被引:3
|
作者
Drummond, Michael [1 ,2 ]
Federici, Carlo [2 ]
Busink, Ellen [3 ]
Apel, Christian [3 ]
Kendzia, Dana [3 ]
Brouwer, Werner [4 ]
机构
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[2] Bocconi Univ, Ctr Res Hlth & Social Care, Milan, Italy
[3] Fresenius Med Care, Hlth Econ & Market Access EMEA, Bad Homburg, Germany
[4] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands
关键词
Health technology assessment; reimbursement; risk sharing; performance assessment; cost-effectiveness analysis;
D O I
10.1080/14737167.2021.1876566
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction Performance-based risk-sharing agreements (PBRSAs), between payers, health care providers, and technology manufacturers can be useful when there is uncertainty about the (cost-) effectiveness of a new technology or service. However, they can be challenging to design and implement. Areas covered A total of 18 performance-based agreements were identified through a literature review. All but two of the agreements identified were pay-for-performance schemes, agreed between providers and payers at the national level. No examples were found of agreements between health care providers and manufacturers at the local level. The potential for these local agreements was illustrated by hypothetical case studies of water quality management and an integrated chronic kidney disease program. Expert opinion Performance-based risk-sharing agreements can work to the advantage of patients, health care providers, payers, and technology manufacturers, particularly if they facilitate the introduction of technologies or systems of care that might not have been introduced otherwise. However, the design, conduct, and implementation of PBRSAs in renal care pose a number of challenges. Efforts should be made to overcome these challenges so that more renal care patients can benefit from technological advances and new models of care.
引用
收藏
页码:197 / 209
页数:13
相关论文
共 50 条
  • [1] Risk-sharing agreements, present and future
    Goncalves, Francisco R.
    Santos, Susana
    Silva, Catarina
    Sousa, Gabriela
    [J]. ECANCERMEDICALSCIENCE, 2018, 12
  • [2] TOWARD AN ECONOMIC FRAMEWORK FOR UNDERSTANDING PERFORMANCE-BASED RISK-SHARING AGREEMENTS FOR INNOVATIVE MEDICAL PRODUCTS
    Garrison, L. P.
    Towse, A.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A488 - A488
  • [3] Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol
    Di Giuseppe, Luis A.
    Buela, Gabriela
    Zacariaz Hereter, Johana B.
    Terrasa, Sergio A.
    Garfi, Leonardo G.
    Soriano, Enrique R.
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2020, 21 : 201 - 204
  • [4] Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol
    Buela, Gabriela
    Di Giuseppe, L. A.
    Zacariaz Hereter, J. B.
    Adrian Terrasa, Sergio
    Garfi, L. A.
    Soriano, E. R.
    [J]. INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2022, 22
  • [5] Performance-Based Risk-Sharing Arrangements: An Updated International Review
    Carlson, Josh J.
    Chen, Shuxian
    Garrison, Louis P., Jr.
    [J]. PHARMACOECONOMICS, 2017, 35 (10) : 1063 - 1072
  • [6] Performance-Based Risk-Sharing Arrangements: An Updated International Review
    Josh J. Carlson
    Shuxian Chen
    Louis P. Garrison
    [J]. PharmacoEconomics, 2017, 35 : 1063 - 1072
  • [7] Emerging roles for pharmacists in performance-based risk-sharing arrangements
    Calabrese, Martin J.
    Cooke, Catherine E.
    Watson, Kristin
    de Bittner, Magaly Rodriguez
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (13) : 1007 - 1012
  • [8] Insurance-based risk-sharing agreements
    Augustin Terlinden
    Amine Aissaoui
    Olivier Ethgen
    [J]. Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [9] International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market
    Xu, Weiwei
    Wu, Jing
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (05) : 486 - 491
  • [10] PERFORMANCE-BASED RISK-SHARING ARRANGEMENTS IN DIAGNOSTICS AND DEVICES IN THE UNITED STATES
    Chen, Y.
    Carlson, J.
    [J]. VALUE IN HEALTH, 2021, 24 : S238 - S238